Stay updated on Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now presents new guidance/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a 'No longer looking for participants' notice. The Intervention/Treatment heading has been updated and the older 'Intervention / Treatment' label removed, alongside a new revision indicator 'Revision: v3.6.0' replacing the previous version.
    Difference
    0.4%
    Check dated 2026-06-12T14:08:30.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.5.4 to v3.5.5, representing a new build of the ClinicalTrials.gov page. It indicates an update to the site software rather than changes to the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-06-05T10:07:11.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page adds a new site revision tag for v3.5.4 and removes the previous v3.5.3 label, signaling a small platform update in the release notes area rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T02:16:05.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a new revision tag (v3.5.3), replacing the previous v3.5.2, indicating a release update to the page's content management without altering study data. No study details or eligibility criteria appear to be changed.
    Difference
    0.1%
    Check dated 2026-04-30T18:41:22.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:44.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The study page now shows 'Results Submitted' instead of 'No Results Posted'.
    Difference
    0.1%
    Check dated 2026-04-09T08:28:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page.